Bank of America
LABP

Bank of America’s Landos Biopharma, Inc. Common Stock LABP Stock Holding History

Bank of America’s Portfolio LABP Stock Details LABP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-3
Closed -$8 – 8139
2023
Q1 		$8 Buy
+3
New +$11 ﹤0.01% 7652
2022
Q4 		– Sell
-1,648
Closed -$11K – 8558
2022
Q3 		$11K Sell
1,648
-2,380
-59% -$20.7K ﹤0.01% 7218
2022
Q2 		$29K Sell
4,028
-1,604
-28% -$14.6K ﹤0.01% 7060
2022
Q1 		$83K Buy
5,632
+2,509
+80% +$63.8K ﹤0.01% 6954
2021
Q4 		$150K Buy
3,123
+2,974
+1,996% +$313K ﹤0.01% 6660
2021
Q3 		$22K Sell
149
-973
-87% -$126K ﹤0.01% 7367
2021
Q2 		$130K Sell
1,122
-873
-44% -$97.3K ﹤0.01% 6365
2021
Q1 		$193K Buy
+1,995
New +$260K ﹤0.01% 6069

Other funds holding LABP

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America's LABP Position: Q2 2023 in Review

Bank of America sold out of Landos Biopharma, Inc. Common Stock (LABP) in Q2 2023, closing a stake of 3 shares — an estimated $8 sold.

Bank of America first reported a position in LABP in Q1 2021 and held it in 8 quarters. The position peaked at $193K in Q1 2021. 8 funds tracked by Wall St. Rank hold LABP as of Q2 2023.

  • Bank of America reported no remaining Landos Biopharma, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Bank of America sold 3 Landos Biopharma, Inc. Common Stock shares in Q2 2023, an estimated $8.
  • Bank of America first reported a position in Landos Biopharma, Inc. Common Stock in Q1 2021 and held it in 8 quarters.
  • Bank of America's Landos Biopharma, Inc. Common Stock position peaked at $193K in Q1 2021.
  • 8 funds tracked by Wall St. Rank held Landos Biopharma, Inc. Common Stock as of Q2 2023.

Based on Bank of America's 13F filing for Q2 2023, filed 14 Aug 2023.